speb/financial-data huggingface dataset:
REP.MC cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -631000000.00
REP.MC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1610000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -40000000.00
REP.MC income_statement (annual, 2024-12-31) — Net Interest Income: 129000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Net Interest Income: -97000000.00
REP.MC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 2391000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 1181000000.00
REP.MC income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 129000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -97000000.00
REP.MC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1100000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -837000000.00
REP.MC cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 271000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 122000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Net PPE: 27977000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Net PPE: 27977000000.00
REP.MC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4582000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -1022000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 23364000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 23364000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 4405000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 4405000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2658000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2658000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 95000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 95000000.00
REP.MC income_statement (annual, 2024-12-31) — Normalized EBITDA: 6337000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 2126000000.00
REP.MC income_statement (annual, 2024-12-31) — Normalized Income: 2298596685.08
REP.MC income_statement (quarterly, 2024-12-31) — Normalized Income: 1121500000.00
REP.MC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 4965000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 1608000000.00
REP.MC income_statement (annual, 2024-12-31) — Operating Income: 2607000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Operating Income: 866000000.00
REP.MC income_statement (annual, 2024-12-31) — Operating Revenue: 57122000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Operating Revenue: 27199000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1157208033.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 1157208033.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Current Assets: 296000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 296000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Equity Interest: 2291000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 2291000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2605000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 2605000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Inventories: 513000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Inventories: 513000000.00
REP.MC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 49000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 445000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 770000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 770000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 654000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 654000000.00
REP.MC income_statement (annual, 2024-12-31) — Other Operating Expenses: 4710000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 3766000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Payable: 4983000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Payable: 4983000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Properties: 4708000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Properties: 4708000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Receivables: 1084000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1084000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1670000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 1670000000.00
REP.MC income_statement (annual, 2024-12-31) — Other Special Charges: -2000000.00
REP.MC income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
REP.MC income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
REP.MC balance_sheet (annual, 2024-12-31) — Payables: 10964000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Payables: 10964000000.00
REP.MC income_statement (annual, 2024-12-31) — Pretax Income: 2172000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Pretax Income: -361000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Properties: 28667000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Properties: 28667000000.00
REP.MC cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1246000000.00
REP.MC cash_flow (annual, 2024-12-31) — Purchase Of Business: -1142000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -160000000.00
REP.MC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1770000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -153000000.00
REP.MC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -5106000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -1305000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Raw Materials: 572000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Raw Materials: 572000000.00
REP.MC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 46216000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 22240000000.00
REP.MC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2932000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 830000000.00
REP.MC income_statement (annual, 2024-12-31) — Rent And Landing Fees: 242000000.00
REP.MC income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 242000000.00
REP.MC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1135000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Retained Earnings: 18193000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 18193000000.00
REP.MC cash_flow (annual, 2024-12-31) — Sale Of Business: 368000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Sale Of Business: 164000000.00
REP.MC cash_flow (annual, 2024-12-31) — Sale Of Investment: 4161000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 1334000000.00
REP.MC cash_flow (annual, 2024-12-31) — Sale Of PPE: 524000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 283000000.00
REP.MC income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1784000000.00
REP.MC income_statement (annual, 2024-12-31) — Selling General And Administration: 2385000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Share Issued: 1157396053.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Share Issued: 1157396053.00
REP.MC income_statement (annual, 2024-12-31) — Special Income Charges: -987000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Special Income Charges: -1361000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 26489000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 26489000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 23364000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 23364000000.00
REP.MC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -189403314.92
REP.MC income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -330500000.00
REP.MC income_statement (annual, 2024-12-31) — Tax Provision: 562000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Tax Provision: -321000000.00
REP.MC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.26
REP.MC income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
REP.MC balance_sheet (annual, 2024-12-31) — Taxes Receivable: 697000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 697000000.00
REP.MC cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -51000000.00
REP.MC cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: 212000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Assets: 63186000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Assets: 63186000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Capitalization: 32908000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 32908000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Debt: 12185000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Debt: 12185000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 29099000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 29099000000.00
REP.MC income_statement (annual, 2024-12-31) — Total Expenses: 54515000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Total Expenses: 26333000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 34087000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 34087000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 41922000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 41922000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 18404000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 18404000000.00
REP.MC income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1945000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -462000000.00
REP.MC income_statement (annual, 2024-12-31) — Total Other Finance Cost: -59000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -89000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 507000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 507000000.00
REP.MC income_statement (annual, 2024-12-31) — Total Unusual Items: -732000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items: -1322000000.00
REP.MC income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -732000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1322000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 188020.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 188020.00
REP.MC balance_sheet (annual, 2024-12-31) — Treasury Stock: 2000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 2000000.00
REP.MC balance_sheet (annual, 2024-12-31) — Working Capital: 5581000000.00
REP.MC balance_sheet (quarterly, 2024-12-31) — Working Capital: 5581000000.00
REP.MC income_statement (annual, 2024-12-31) — Write Off: 989000000.00
REP.MC income_statement (quarterly, 2024-12-31) — Write Off: 33000000.00
REP.MC income_statement (quarterly, 2025-03-31) — +Operating Expense: 1971000000.00
REP.MC income_statement (quarterly, 2025-03-31) — +Total Revenue: 14408000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10364000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7448000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 22415000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 2408000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1220000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.30
REP.MC cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4758000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -938000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1157000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3270000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6550000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -569000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -349000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1415000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Common Stock: 1157000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -569000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 26161000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 5000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -136000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 11784000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Current Assets: 23033000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 17701000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1354000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Depreciation: 641000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 641000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1220000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.30
REP.MC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 366000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 13000000.00
REP.MC income_statement (quarterly, 2025-03-31) — EBIT: 732000000.00
REP.MC income_statement (quarterly, 2025-03-31) — EBITDA: 1373000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -73000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — End Cash Position: 3270000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -983000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 86000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3068000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Gross Profit: 2624000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Interest Expense: 65000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 65000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Interest Income: 72000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 72000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -111000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Inventory: 6118000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 26161000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1456000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 905000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 5000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3351000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 2896000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Minority Interest: 2521000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Minority Interests: -27000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -119000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -131000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income: 366000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 366000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 393000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 366000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 366000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 667000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 393000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Interest Income: -5000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -670000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -45000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 33000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Net PPE: 26628000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -700000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 23093000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 3112000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2597000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1516000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Normalized Income: 451800000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1024000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Operating Income: 653000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Operating Revenue: 14408000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1150029067.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 509000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2288000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -64000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1494000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1006000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1004000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3280000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Payables: 10364000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Pretax Income: 667000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -200000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1107000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -938000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 11784000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 641000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -136000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 366000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Sale Of Business: 81000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 437000000.00
REP.MC cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 238000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 398000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 398000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Share Issued: 1157396053.00
REP.MC income_statement (quarterly, 2025-03-31) — Special Income Charges: -53000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 26161000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 23093000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -57200000.00
REP.MC income_statement (quarterly, 2025-03-31) — Tax Provision: 274000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.40
REP.MC cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 254000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Assets: 61591000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 26161000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 28682000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Total Expenses: 13755000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 32909000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 38558000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15208000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 570000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 12000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items: -143000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -143000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 7366986.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 137000000.00
REP.MC balance_sheet (quarterly, 2025-03-31) — Working Capital: 5332000000.00
REP.MC income_statement (quarterly, 2025-03-31) — Write Off: 53000000.00
REP.MC income_statement (quarterly, 2025-06-30) — +Operating Expense: 1969000000.00
REP.MC income_statement (quarterly, 2025-06-30) — +Total Revenue: 13530000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10258000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6969000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 21233000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 3294000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3270000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1014000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1157000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3509000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6510000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -28000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 688000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Changes In Cash: 299000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Common Stock: 1157000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -28000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 23829000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11152000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Current Assets: 22356000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 18131000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Current Provisions: 1540000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Depreciation: 478000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 584000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 237000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 32000000.00
REP.MC income_statement (quarterly, 2025-06-30) — EBIT: 493000000.00
REP.MC income_statement (quarterly, 2025-06-30) — EBITDA: 1077000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -60000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — End Cash Position: 3509000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -742000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 548000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2951000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Gross Profit: 2378000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Interest Expense: 54000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 54000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Interest Income: 65000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 65000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -89000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Inventory: 5132000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 23829000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -521000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 971000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 3084000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2725000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Minority Interest: 2524000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Minority Interests: -63000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -53000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -113000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income: 237000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 237000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 300000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 237000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 237000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 439000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 300000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Interest Income: -30000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 474000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -30000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -512000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 49000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Net PPE: 25120000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -991000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 20878000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 3207000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2441000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1339000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Normalized Income: 416043280.18
REP.MC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1562000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Operating Income: 409000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Operating Revenue: 13530000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1136585879.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 451000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 2419000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 125000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1371000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 891000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1100000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 3001000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Payables: 10258000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Pretax Income: 439000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -55000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -763000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1014000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11152000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 584000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 603000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Sale Of Business: 2000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1237000000.00
REP.MC cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 23000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 375000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Selling General And Administration: 657000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Share Issued: 1157396053.00
REP.MC income_statement (quarterly, 2025-06-30) — Special Income Charges: 36000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 23829000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 20878000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -82956719.82
REP.MC income_statement (quarterly, 2025-06-30) — Tax Provision: 139000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.32
REP.MC cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -256000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Assets: 59060000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 23829000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 26353000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Total Expenses: 13121000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 32707000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 36704000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 14576000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 448000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 41000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items: -262000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -262000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 20810174.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 245000000.00
REP.MC balance_sheet (quarterly, 2025-06-30) — Working Capital: 4225000000.00
REP.MC income_statement (quarterly, 2025-06-30) — Write Off: -22000000.00
REP.MC income_statement (annual, 2025-12-31) — +Operating Expense: 7789000000.00
REP.MC income_statement (quarterly, 2025-12-31) — +Operating Expense: 4092000000.00
REP.MC income_statement (annual, 2025-12-31) — +Total Revenue: 54861000000.00
REP.MC income_statement (quarterly, 2025-12-31) — +Total Revenue: 26923000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Accounts Payable: 4646000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4646000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5215000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5215000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -36113000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -36113000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4038000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4038000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -155000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -155000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 1227000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 1227000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 183000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 183000000.00
REP.MC income_statement (annual, 2025-12-31) — Basic Average Shares: 1132000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1157142857.00
REP.MC income_statement (annual, 2025-12-31) — Basic EPS: 1.62
REP.MC income_statement (quarterly, 2025-12-31) — Basic EPS: 1.12
REP.MC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4758000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 4271000000.00
REP.MC cash_flow (annual, 2025-12-31) — Capital Expenditure: -3746000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1025000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2894000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2894000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Capital Stock: 1105000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1105000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 3261000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 3261000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7654000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7654000000.00
REP.MC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1197000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -32000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Cash Equivalents: 984000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 984000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Cash Financial: 2277000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Cash Financial: 2277000000.00
REP.MC cash_flow (annual, 2025-12-31) — Change In Inventory: 172000000.00
REP.MC cash_flow (annual, 2025-12-31) — Change In Payable: 149000000.00
REP.MC cash_flow (annual, 2025-12-31) — Change In Receivables: 286000000.00
REP.MC cash_flow (annual, 2025-12-31) — Change In Working Capital: 607000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 261000000.00
REP.MC cash_flow (annual, 2025-12-31) — Changes In Cash: -1272000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1023000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Common Stock: 1105000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Common Stock: 1105000000.00
REP.MC cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -1197000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -32000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 25140000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 25140000000.00
REP.MC cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1511000000.00
REP.MC cash_flow (annual, 2025-12-31) — Common Stock Payments: -1485000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Construction In Progress: 3814000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 3814000000.00
REP.MC income_statement (annual, 2025-12-31) — Cost Of Revenue: 44492000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 21195000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Assets: 21373000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Assets: 21373000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 554000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 554000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Debt: 1284000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Debt: 1284000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1838000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1838000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Liabilities: 13880000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 13880000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Current Provisions: 1177000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Current Provisions: 1177000000.00
REP.MC cash_flow (annual, 2025-12-31) — Depreciation: 2439000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Depreciation: 649000000.00
REP.MC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2439000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 649000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 246000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 246000000.00
REP.MC income_statement (annual, 2025-12-31) — Diluted Average Shares: 1132000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1157142857.00
REP.MC income_statement (annual, 2025-12-31) — Diluted EPS: 1.62
REP.MC income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.12
REP.MC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1899000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1296000000.00
REP.MC cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 93000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 28000000.00
REP.MC income_statement (annual, 2025-12-31) — EBIT: 3289000000.00
REP.MC income_statement (quarterly, 2025-12-31) — EBIT: 2040000000.00
REP.MC income_statement (annual, 2025-12-31) — EBITDA: 5728000000.00
REP.MC income_statement (quarterly, 2025-12-31) — EBITDA: 2689000000.00
REP.MC cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -225000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 13000000.00
REP.MC cash_flow (annual, 2025-12-31) — End Cash Position: 3261000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — End Cash Position: 3261000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Financial Assets: 43000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Financial Assets: 43000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 50000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 50000000.00
REP.MC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -864000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -317000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Finished Goods: 4261000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Finished Goods: 4261000000.00
REP.MC cash_flow (annual, 2025-12-31) — Free Cash Flow: 1619000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 487000000.00
REP.MC cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 284000000.00
REP.MC income_statement (annual, 2025-12-31) — General And Administrative Expense: 589000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Goodwill: 509000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Goodwill: 509000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2920000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2920000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 5370000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 5370000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Gross PPE: 61765000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 61765000000.00
REP.MC income_statement (annual, 2025-12-31) — Gross Profit: 10369000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Gross Profit: 5728000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 228000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 228000000.00
REP.MC income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: -1000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: -55000000.00
REP.MC income_statement (annual, 2025-12-31) — Interest Expense: 472000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Interest Expense: 329000000.00
REP.MC income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 472000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 329000000.00
REP.MC income_statement (annual, 2025-12-31) — Interest Income: 473000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Interest Income: 120000000.00
REP.MC income_statement (annual, 2025-12-31) — Interest Income Non Operating: 473000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 120000000.00
REP.MC cash_flow (annual, 2025-12-31) — Interest Paid Cff: -407000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -97000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Inventory: 5475000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Inventory: 5475000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Invested Capital: 35484000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 35484000000.00
REP.MC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5773000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2218000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Investment Properties: 21000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Investment Properties: 21000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 183000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 183000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 437000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 437000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 3284000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 3284000000.00
REP.MC cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1511000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Land And Improvements: 3557000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 3557000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2340000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2340000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Long Term Debt: 9060000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 9060000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11400000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11400000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 3721000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 3721000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 3002000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 3002000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 27541000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 27541000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Minority Interest: 2478000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 2478000000.00
REP.MC income_statement (annual, 2025-12-31) — Minority Interests: -201000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Minority Interests: -111000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 272000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -35000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 26000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 325000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Net Debt: 7083000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Net Debt: 7083000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -468000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income: 1899000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income: 1296000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1899000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1296000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2100000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1407000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1899000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1296000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1899000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1296000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2817000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 782000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2100000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1407000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Interest Income: 30000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Interest Income: -105000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2763000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1260000000.00
REP.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 30000000.00
REP.MC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -105000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 971000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -383000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 147000000.00
REP.MC cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 51000000.00
REP.MC balance_sheet (annual, 2025-12-31) — Net PPE: 25652000000.00
REP.MC balance_sheet (quarterly, 2025-12-31) — Net PPE: 25652000000.00
REP.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3429000000.00